Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

In an unprecedented effort, a coalition of more than 50 research teams has surveyed a swathe of Brazilian biomedical studies to double-check their findings — with dismaying results. The teams ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...

The potential diversion of government funds for biomedical research has sparked intense debate in recent weeks. Understandably, many in the medical and scientific communities are concerned about ...

Our research is aimed at understanding the molecular and cellular processes underlying human health and disease with a key aim to translate this research into diagnostic and therapeutic applications.

The new San Diego hub is billed as the heart of the Novartis West Coast Biomedical Research ... in Carlsbad and the Genomics Institute of the Novartis Research Foundation in Torrey Pines.

Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well as open a second global biomedical research hub in San Diego.

Novartis plans to expand its U.S. manufacturing ... It is also planning a $1.1B biomedical research hub in San Diego, two new radioligand therapy manufacturing facilities in Florida and Texas ...

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...

SAN DIEGO — Novartis, a Swiss pharmaceutical company ... According to the company, one of its biomedical research innovation hubs will be based in San Diego, and it will look to expand three ...

Novartis announced it will spend $23 billion to construct ... including two radioligand therapy manufacturing facilities in Florida and Texas, and a new $1 billion biomedical research hub in San Diego ...